Liquid stable bovine virus vaccines
AssigneeIntervet Inc.
InventorsSandhya BUCHANAN, Kevin O'CONNELL
Life of this patent
Estimating the term…
Abstract
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, in sucrose, arginine, and methionine. The present invention also discloses the manufacture of such vaccines and methods of protecting an animal by administration of such vaccines.
Claims20
A liquid stable vaccine that comprises a live attenuated bovine virus, 20-40% (w/v) sucrose, 0.15 to 0.75 M arginine, and 0.025 to 0.3 M methionine;
- wherein the liquid stable vaccine has a pH of 6.0 to 8.0
A method of making a liquid stable vaccine that comprises combining a therapeutically effective amount of a live attenuated bovine virus with 20-40% (w/v) sucrose, 0.15 to 0.75 M arginine, and 0.025 to 0.3 M methionine;
- wherein the liquid stable vaccine has a pH of 6.0 to 8.0.
Dependencies are inferred from the claim text.